TrialMultiple sclerosis (Houndmills, Basingstoke, England)2019

Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study.

Gavin Giovannoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.